Targeting the LRP5 Pathway Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta-Reference-Cited by-同舟云学术

Targeting the LRP5 Pathway Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta

Published:2014-09-26 Issue:10 Volume:29 Page:2297-2306
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Jacobsen Christina M¹²³⁴,Barber Lauren A¹,Ayturk Ugur M¹⁵,Roberts Heather J¹,Deal Lauren E⁶,Schwartz Marissa A¹,Weis MaryAnn⁷,Eyre David⁷,Zurakowski David⁸,Robling Alexander G⁶,Warman Matthew L¹⁵⁹

Affiliation:

1. Orthopaedic Research Laboratories; Department of Orthopaedic Surgery, Boston Children's Hospital; Boston MA USA

2. Division of Endocrinology; Boston Children's Hospital; Boston MA USA

3. Division of Genetics; Boston Children's Hospital; Boston MA USA

4. Department of Pediatrics; Harvard Medical School; Boston MA USA

5. Department of Genetics; Harvard Medical School; Boston MA USA

6. Department of Anatomy and Cell Biology; Indiana University; Indianapolis IN USA

7. Department of Orthopedics and Sports Medicine; University of Washington; Seattle WA USA

8. Department of Anesthesia; Children's Hospital Boston; Boston MA USA

9. Howard Hughes Medical Institute; Boston MA USA

Funder

Osteogenesis Imperfecta Foundation Michael Geisman Fellowship

Pediatric Endocrinology Society Research Fellowship

NIAMS/NIH

NICHD/NIH

Howard Hughes Medical Institute

Melissa Cummings and Animal Resources at Children's Hospital

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference52 articles.

1. Recent advances in osteogenesis imperfecta;Cundy;Calcif Tissue Int.,2012

2. Recessively inherited forms of osteogenesis imperfecta;Byers;Annu Rev Genet.,2012

3. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta;Glorieux;N Engl J Med.,1998

4. Intravenous bisphosphonate therapy in children with osteogenesis imperfecta;Falk;Pediatrics.,2003

5. Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution;Alharbi;Horm Res.,2009

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining anabolic loading and raloxifene improves bone quantity and some quality measures in a mouse model of osteogenesis imperfecta;Bone;2024-07

2. Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives;Journal of Orthopaedic Translation;2024-07

3. Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential;Molecular Therapy - Nucleic Acids;2024-03

4. New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review;Journal of Clinical Medicine;2024-02-13

5. RNA-based bone histomorphometry: method and its application to explaining postpubertal bone gain in a G610C mouse model of osteogenesis imperfecta;Journal of Bone and Mineral Research;2024-01-04